NEW YORK, Oct. 30 - Molecular Staging’s microarray-based protein-detection and -amplification technology is as accurate as traditional tests for allergen specific IgE, according to results of a recent study .

New Haven, Conn.-based MSI is developing this technology, called Rolling Circle Amplification Technology, for use in a protein-chip approach to diagnostics. MSI is currently working on applications in immunodiagnostic and gene-based diagnostic markets.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.